Study of the correlation of epicardial adipose tissue with left ventricular mass and left ventricular mass index in patients with essential hypertension
DOI:
https://doi.org/10.18203/2320-6012.ijrms20200257Keywords:
Epicardial adipose tissue, Essential hypertension, Left ventricular mass, Left ventricular mass indexAbstract
Background: Epicardial Adipose Tissue (EAT) is recognized to be a cardiovascular risk factor. In addition to providing fuel to heart, it plays a pivotal role in the pathogenesis of atherosclerosis though the secretion of adipokines. This study aims to find the correlation of EAT with Left Ventricular Mass (LVM) and Left Ventricular Mass Index (LVMI) in patients with essential hypertension. Increasing LVM and LVMI are predictors of poor cardiovascular outcome. So, if we find a positive correlation, we can say that measurement of epicardial fat in essential hypertension may help us identify high risk hypertensive patients.
Methods: This study was carried out in SMS Hospital, Jaipur, after approval from the Ethics Committee. 100 consecutive eligible patients were included in the study after application of inclusion and exclusion criteria and taking proper informed consent. After history, examination and routine laboratory investigations, all patients underwent transthoracic 2D and Doppler echocardiography. EAT thickness, LVM and LVMI were measured and correlated using Spearman correlation coefficient.
Results: The mean LVM was 139±42.12 g and mean LVMI was 35.76±11.28 g/m2.7. The spearman correlation coefficient (r) was calculated to be 0.691 between EAT and LVM and 0.677 between EAT and LVMI, indicating strong positive correlation between EAT and both LVM and LVMI. This implies that as; EAT increases, LVM and LVMI increases significantly.
Conclusions: Thus, authors have found that EAT is positively correlated with LVM and LVMI. So, we can say that increase in EAT may lead to adverse cardiovascular outcome in patients with essential hypertension.
Metrics
References
Global Health Estimates 2016. Deaths by Cause, Age, Sex, by Country and by Religion, 2000-2016. Geneva, World Health Organization; 2018. Available at: http://origin.who.int/healthinfo/global_burdendisease/estimates/en/. Accessed 15 March 2018.
Talman AH, Psaltis PJ, Cameron JD, Meredith IT, Seneviratne SK, Wong DT. Epicardial adipose tissue: far more than a fat depot. Cardiovasc Diag Ther. 2014 Dec;4(6):416.
Rabkin SW. Epicardial fat: properties, function and relationship to obesity. Obes Rev. 2007 May;8(3):253-61.
Iacobellis G, Bianco AC. Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. Trends Endocrinol Metab. 2011 Nov 1;22(11):450-7.
Sacks HS, Fain JN, Holman B, Cheema P, Chary A, Parks F, et al. Uncoupling protein-1 and related messenger ribonucleic acids in human epicardial and other adipose tissues: epicardial fat functioning as brown fat. J Clin Endocrinol Metab. 2009 Sep 1;94(9):3611-5.
Prati F, Arbustini E, Labellarte A, Sommariva L, Pawlowski T, Manzoli A, et al. Eccentric atherosclerotic plaques with positive remodelling have a pericardial distribution: a permissive role of epicardial fat? A three-dimensional intravascular ultrasound study of left anterior descending artery lesions. Eur Heart J. 2003 Feb 1;24(4):329-36.
Fitzgibbons TP, Czech MP. Epicardial and perivascular adipose tissues and their influence on cardiovascular disease: basic mechanisms and clinical associations. J Am Heart Assoc. 2014 Mar 4;3(2):e000582.
Han SH, Sakuma I, Shin EK, Koh KK. Antiatherosclerotic and anti-insulin resistance effects of adiponectin: basic and clinical studies. Progr Cardiovasc Dis. 2009 Sep 1;52(2):126-40.
Sacks HS, Fain JN. Human epicardial adipose tissue: a review. Am Heart J. 2007 Jun 1;153(6):907-17.
Turak O, Özcan F, Canpolat U, Mendi MA, Öksüz F, Özeke Ö, et al. Relation between epicardial adipose tissue thickness and blood pressure levels in prehypertension. Arch Turk Soc Cardiol. 2014 Jun 1;42(4):358-64.
Erdogan T, Çetin M, Kocaman SA, Durakoglugil ME, Ergül E, Ugurlu Y, et al. Epicardial adipose tissue is independently associated with increased left ventricular mass in untreated hypertensive patients: an observational study. Anadulu Kardiyol Derg. 2013 Jun 1;13(4):320.
Khawaja T, Greer C, Chokshi A, Chavarria N, Thadani S, Jones M, et al. Epicardial fat volume in patients with left ventricular systolic dysfunction. Am J Cardiol. 2011 Aug 1;108(3):397-401.
Muñoz MJ, Acevedo LB, Pérez NC, Martínez AL, Gutiérrez NT, García SV, et al. Epicardial adipose tissue is associated with visceral fat, metabolic syndrome, and insulin resistance in menopausal women. Revista Española de Cardiol. 2014 Jun 1;67(6):436-41.
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imag. 2015 Feb 18;16(3):233-71.
Devereux RB, Lutas EM, Casale PN, Kligfield P, Eisenberg RR, Hammond IW, et al. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Col Cardiol. 1984 Dec 1;4(6):1222-30.
Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F. Relation between epicardial adipose tissue and left ventricular mass. Am J Cardiology. 2004 Oct 15;94(8):1084-7.
Mookadam F, Goel R, Alharthi MS, Jiamsripong P, Cha S. Epicardial fat and its association with cardiovascular risk: a cross-sectional observational study. Heart Views: Official J Gulf Heart Association. 2010 Oct;11(3):103-8.
Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003 Nov 18;108(20):2460-6.
Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proceed Nutr Soc. 2001 Aug;60(3):329-39.
Shioji K, Moriguchi A, Moriwaki S, Manabe K, Takeuchi Y, Uegaito T, et al. Hypoadiponectinemia implies the development of atherosclerosis in carotid and coronary arteries. J Cardiol. 2005 Sep;46(3):105-12.
Iacobellis G, Pistilli D, Gucciardo M, Leonetti F, Miraldi F, Brancaccio G, et al. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine. 2005 Mar 21;29(6):251-5.
Hirata Y, Tabata M, Kurobe H, Motoki T, Akaike M, Nishio C, et al. Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. J Am Col Cardiol. 2011 Jul 12;58(3):248-55.
Kremen J, Dolinkova M, Krajickova J, Blaha J, Anderlova K, Lacinova Z, et al. Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J Clini Endocrinol Metab. 2006 Nov 1;91(11):4620-7.
Goeller M, Achenbach S, Marwan M, Doris MK, Cadet S, Commandeur F, et al. Epicardial adipose tissue density and volume are related to subclinical atherosclerosis, inflammation and major adverse cardiac events in asymptomatic subjects. J Cardiovasc Comp Tomograp. 2018 Jan 1;12(1):67-73.
Jeong JW, Jeong MH, Yun KH, Oh SK, Park EM, Kim YK, et al. Echocardiographic epicardial fat thickness and coronary artery disease. Circulat J. 2007;71(4):536-9.
Ahn SG, Lim HS, Joe DY, Kang SJ, Choi BJ, Choi SY, et al. Relationship of epicardial adipose tissue by echocardiography to coronary artery disease. Heart. 2008 Mar 1;94(3):e7.
Eroglu S, Sade LE, Yildirir A, Bal U, Ozbicer S, Ozgul AS, et al. Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease. Nutr, Metab Cardiovasc Dis. 2009 Mar 1;19(3):211-7.
Kamal D, ElMoteleb AM, Samir R, Saeed M. Epicardial fat thickness can predict severity and multivessel distribution in Egyptian patients with atherosclerotic coronary artery stenosis. Egypt Heart J. 2018 Dec 1;70(4):323-7.